DYII / Dynacq Healthcare, Inc. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Termination of a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2016 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-21574 (Commission File Numbe

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K 1 v4505218k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2016 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-2

Dynacq Healthcare NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-21574 CUSIP NUMBER: 26779V105 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: February 29, 2016 ? Transition Report on Form 10-K and Form 10-KSB ? Transition Report on Form 20-F ? Transition Report

DYII / Dynacq Healthcare, Inc. / Chan Eric K. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Eric K. Chan Chief Executive Officer Dynacq Healthcare, Inc. 4301 Vista Road Pasadena, Texas 77504 Telephone: (713

DYII / Dynacq Healthcare, Inc. / Chan Eric K. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Eric K. Chan Chief Executive Officer Dynacq Healthcare, Inc. 4301 Vista Road Pasadena, Texas 77504 Telephone: (713

DYII / Dynacq Healthcare, Inc. / Chan Ella Y. T. C. - AMENDMENT NO. 4 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Ella Y. T. C. Chan 323 Wood Loop St. Houston, Texas 77015 (713) 582-0403 (Name, Address and Telephone Number of Pe

DYII / Dynacq Healthcare, Inc. / Chan Eric K. - AMENDMENT NO. 1 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Eric K. Chan Chief Executive Officer Dynacq Healthcare, Inc. 4301 Vista Road Pasadena, Texas 77504 Telephone: (713

DYII / Dynacq Healthcare, Inc. / Chan Ella Y. T. C. - AMENDMENT NO. 3 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Ella Y. T. C. Chan 323 Wood Loop St. Houston, Texas 77015 (713) 582-0403 (Name, Address and Telephone Number of Pers

DYII / Dynacq Healthcare, Inc. / Chan Eric K. - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. )* Under the Securities Exchange Act of 1934 Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Eric K. Chan Chief Executive Officer Dynacq Healthcare, Inc. 4301 Vista Road Pasadena, Texas 77504 Telephone: (713) 3

Dynacq Healthcare 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-21574 DYNACQ HE

Dynacq Healthcare SCHEDULE 14D-9

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company) DYNACQ HEALTHCARE, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number of Class

DYII / Dynacq Healthcare, Inc. / Cemekc, Inc. - SC TO-T

SC TO-T 1 v427224scto-t.htm SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company (Issuer)) ERIC K. CHAN CEMEKC, INC. ELLA Y. T. C. CHAN CHIU M. CHAN FAMILY TRUST (Name of Filing Persons (Offeror)) Common Stock, par

LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DYNACQ HEALTHCARE, INC. AT $0.10 NET PER SHARE IN CASH PURSUANT TO THE OFFER TO PURCHASE DATED DECEMBER 18, 2015 BY ERIC K. CHAN ELLA Y. T. C. CHAN CHIU M. CHAN FAMILY TRUST CEMEKC, INC.

Exhibit (a)(1)(ii) LETTER OF TRANSMITTAL TO TENDER SHARES OF COMMON STOCK OF DYNACQ HEALTHCARE, INC.

Notice of Guaranteed Delivery Tender of Shares of Common Stock Dynacq Healthcare, Inc. Eric K. Chan Ella Y. T. C. Chan Chiu M. Chan Family Trust CEMEKC, Inc.

Exhibit (a)(1)(iii) Notice of Guaranteed Delivery for Tender of Shares of Common Stock of Dynacq Healthcare, Inc.

Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc. at $0.10 Per Share by Eric K. Chan Ella Y. T. C. Chan Chiu M. Chan Family Trust and CEMEKC, Inc. The Offer and withdrawal rights will expire at 11:59 PM, New

Exhibit (a)(1)(i) Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc.

Offer to Purchase for Cash All Outstanding Shares of Common Stock Dynacq Healthcare, Inc. $0.10 Net Per Share Eric K. Chan Ella Y. T. C. Chan Chiu M. Chan Family Trust CEMEKC, Inc.

Exhibit (a)(1)(iv) Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc.

Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc. at $0.10 Net Per Share by Eric K. Chan Ella Y. T. C. Chan Chiu M. Chan Family Trust and CEMEKC, Inc.

Exhibit (a)(1)(v) Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc.

EX-99.(A)(1)(VI)

EX-99.(A)(1)(VI) 7 v427224ex99-a1vi.htm EXHIBIT (A)(1)(VI) Exhibit (a)(1)(vi) 1 2 3 4

Notice of Offer to Purchase for Cash All Outstanding Shares of Common Stock of Dynacq Healthcare, Inc. at $0.10 Net Per Share Pursuant to the Offer to Purchase Dated December 18, 2015 by Eric K. Chan Ella Y. T. C. Chan Chiu M. Chan Family Trust and C

Exhibit (a)(1)(vii) This announcement is not an offer to purchase or a solicitation of an offer to sell Shares (as defined below).

CEMEKC, INC. COMMENCES TENDER OFFER TO PURCHASE REMAINING PUBLIC STAKE IN DYNACQ HEALTHCARE, INC. Offer Price of $0.10 in Cash per Share

Exhibit (a)(1)(viii) CEMEKC, INC. COMMENCES TENDER OFFER TO PURCHASE REMAINING PUBLIC STAKE IN DYNACQ HEALTHCARE, INC. Offer Price of $0.10 in Cash per Share PASADENA, TEXAS, December 18, 2015—CEMEKC, Inc. (“Purchaser”) announced today that it has commenced a tender offer to purchase all of the outstanding shares of Common Stock of Dynacq Healthcare, Inc. not already owned by Dr. Eric K. Chan, Ell

Subsidiaries of the Registrant

Exhibit 21.1 Subsidiaries of the Registrant The Registrant has the following subsidiaries which, except as indicated, do business under their legal names: NAME PLACE OF INCORPORATION/ORGANIZATION Ambulatory Infusion Therapy Specialist, Inc. Texas Doctors Practice Management, Inc. Texas Sino Bond Inc. Limited Hong Kong Surgery Specialty Clinicians, Inc. Texas Vista Community Medical Center, LLP d/b

Dynacq Healthcare 10-K (Annual Report)

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended August 31, 2015 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-21574 DYNACQ HEALTHCARE, INC. (Exact name of

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2015 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-21574 (Commission File Numbe

AMENDMENT TO BYLAWS DYNACQ HEALTHCARE, INC. (A NEVADA CORPORATION)

EXHIBIT 3.1 AMENDMENT TO BYLAWS OF DYNACQ HEALTHCARE, INC. (A NEVADA CORPORATION) Effective as of the date set forth below, the Bylaws of Dynacq Healthcare, Inc., a Nevada corporation (the ?Corporation?), are amended in the following respect: Article XI is hereby added to the Corporation?s Bylaws and reads as follows: ?ARTICLE XI FORUM FOR ADJUDICATION OF DISPUTES To the fullest extent permitted b

Dynacq Healthcare 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-21574 DYNACQ HEALTHC

Dynacq Healthcare FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-21574 DYNACQ HE

Dynacq Healthcare 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2014 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-21574 DYNACQ HE

DYII / Dynacq Healthcare, Inc. NT 10-K - - NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-21574 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2014 ¨ Transition Report on Form 10-K and Form 10-KSB ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Rep

Submission of Matters to a Vote of Security Holders - 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2014 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-21574 (Commission File Number) 7

- DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement Dynacq Healthcare, Inc. (Name of Reg

- AMENDMENT TO FORM SC TO-T

SC TO-T/A 1 scto-ta.htm AMENDMENT TO FORM SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 3) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company (Issuer)) Furlong Fund, LLC; Furlong Financial, LLC; Daniel Rudewicz (Bidders) Common Stock, $0.001 Pa

STANDSTILL AGREEMENT

EX-99.(d)(1)(A) EX-99.(d)(1)(A) STANDSTILL AGREEMENT This STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of March 14, 2014, between Furlong Fund, LLC, a Delaware limited liability company, and Furlong Financial, LLC, a Delaware limited liability company, and Daniel Rudewicz (collectively, the “Bidder”), on the one hand, and Dynacq Healthcare, Inc., a Nevada corporation (the “C

NOTICE OF OFFER TO PURCHASE FOR CASH 1,356,020 Shares of Common Stock of Dynacq Healthcare, Inc. at $0.03 PER SHARE by Furlong Fund, LLC.

EX-99.(a)(5)(C) EX-99.(a)(5)(C) This announcement is not an offer to purchase or a solicitation of an offer to sell shares. The Offer (as defined below) is made solely by the Amended and Restated Offer to Purchase dated February 28, 2014 and the related Letter of Transmittal and any amendments or supplements thereto and is being made to all holders of shares. The Offer is not being made to, nor wi

- AMENDMENT TO FORM SC TO-T

SC TO-T/A 1 scto-ta.htm AMENDMENT TO FORM SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 2) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company (Issuer)) Furlong Fund, LLC; Furlong Financial, LLC; Daniel Rudewicz (Bidders) Common Stock, $0.001 Pa

- SC 14D9

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company) DYNACQ HEALTHCARE, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number of Class

STANDSTILL AGREEMENT

STANDSTILL AGREEMENT This STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of March 17, 2014, between Furlong Fund, LLC, a Delaware limited liability company, and Furlong Financial, LLC, a Delaware limited liability company, and Daniel Rudewicz (collectively, the “Bidder”), on the one hand, and Dynacq Healthcare, Inc.

Amended and Restated NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock DYNACQ HEALTHCARE, INC. $0.03 PER SHARE Pursuant to the Offer to Purchase Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CI

EX-99.(a)(1)(I) Amended and Restated NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE Pursuant to the Offer to Purchase by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON MARCH 24, 2014, UNLESS EXTENDED. This Notice of Guaranteed Delivery, or a form substantially equivalent hereto, m

Amended and Restated OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock DYNACQ HEALTHCARE, INC. $0.03 PER SHARE Furlong Fund, LLC.

EX-99.(a)(1)(J) Amended and Restated OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC. February 28, 2014 To Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees: Alliance Advisors, LLC (“we” or “our”) has been appointed by Furlong Fund, LLC, a Delaware limited liability company, (“Furlong Fund”), to act

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company (Issuer)) Furlong Fund, LLC; Furlong Financial, LLC; Daniel Rudewicz (Bidders) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 2

FURLONG FUND AMENDS ITS TENDER OFFER FOR SHARES OF DYNACQ HEALTHCARE, INC.

EX-99.(A)(5)(B) 7 ex99-a5b.htm EXHIBIT-99.(A)(5)(B) EX-99.(a)(5)(B) FURLONG FUND AMENDS ITS TENDER OFFER FOR SHARES OF DYNACQ HEALTHCARE, INC. February 28, 2014 –Furlong Fund, LLC (“Furlong” or the “Purchaser”), which is managed by Furlong Financial, LLC, which has as its sole managing member Daniel Rudewicz, has reduced the maximum number of Shares it is offering to purchase to 1,356,200 shares o

OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock DYNACQ HEALTHCARE, INC. $0.03 PER SHARE Furlong Fund, LLC.

EX-99.(a)(1)(K) OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON MARCH 24, 2014, UNLESS EXTENDED. To Our Clients: Enclosed for your consideration are the Offer to Purchase dated February 19, 2014 as amended and supplemented by the Amended a

Amended and Restated LETTER OF TRANSMITTAL To Tender shares of Common Stock Dynacq Healthcare, Inc. Pursuant to the Amended and Restated Offer to Purchase dated February 28, 2014 Furlong Fund, LLC

EX-99.(A)(1)(H) 3 ex99a1h.htm EXHIBIT-99.(A)(1)(H) EX-99.(a)(1)(H) Amended and Restated LETTER OF TRANSMITTAL To Tender shares of Common Stock of Dynacq Healthcare, Inc. Pursuant to the Amended and Restated Offer to Purchase dated February 28, 2014 by Furlong Fund, LLC THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, ON MARCH 24, 2014, UNLESS THE OFFER IS EXTENDED. The Depos

AMENDED AND RESTATED OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock Dynacq Healthcare, Inc. $0.03 per share Furlong Fund, LLC

EX-99.(A)(1)(G) 2 ex99a1g.htm EXHIBIT-99.(A)(1)(G) EX-99.(a)(1)(G) AMENDED AND RESTATED OFFER TO PURCHASE FOR CASH 1,356,200 Shares of Common Stock of Dynacq Healthcare, Inc. At $0.03 per share By Furlong Fund, LLC THE OFFER, WITHDRAWAL RIGHTS, AND PRORATION PERIOD WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME, ON MARCH 24, 2014 UNLESS THE OFFER IS EXTENDED. This offer to acquire shares of common sto

OFFER TO PURCHASE FOR CASH 6,020,306 Shares of Common Stock Dynacq Healthcare, Inc. $0.03 per share Furlong Fund, LLC

EX-99.(A)(1)(A) 2 ex99a1a.htm EX-99.(A)(1)(A) EX-99.(a)(1)(A) OFFER TO PURCHASE FOR CASH 6,020,306 Shares of Common Stock of Dynacq Healthcare, Inc. at $0.03 per share by Furlong Fund, LLC THE OFFER, WITHDRAWAL RIGHTS, AND PRORATION PERIOD WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME, ON MARCH 24, 2014 UNLESS THE OFFER IS EXTENDED. This offer to acquire shares of common stock of Dynacq Healthcare, I

OFFER TO PURCHASE FOR CASH 6,020,3006 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC.

EX-99.(a)(1)(D) EX-99.(a)(1)(D) OFFER TO PURCHASE FOR CASH 6,020,3006 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC. February 19, 2014 To Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees: Alliance Advisors, LLC (“we” or “our”) has been appointed by Furlong Fund, LLC, a Delaware limited liability company, (“Furlong Fund”), to act as

NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE Pursuant to the Offer to Purchase by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON

EX-99.(a)(1)(C) EX-99.(a)(1)(C) NOTICE OF GUARANTEED DELIVERY For Tender of Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE Pursuant to the Offer to Purchase by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON MARCH 24, 2014, UNLESS EXTENDED. This Notice of Guaranteed Delivery, or a form substantially equivalent hereto, must b

NOTICE OF OFFER TO PURCHASE FOR CASH 6,020,306 Shares of Common Stock of Dynacq Healthcare, Inc. (“Dynacq” or the “Company”) at $0.03 PER SHARE by Furlong Fund, LLC.

EX-99.(a)(5)(A) EX-99.(a)(5)(A) This announcement is not an offer to purchase or a solicitation of an offer to sell shares. The Offer (as defined below) is made solely by the Offer to Purchase dated February 19, 2014 and the related Letter of Transmittal and any amendments or supplements thereto and is being made to all holders of shares. The Offer is not being made to, nor will tenders be accepte

OFFER TO PURCHASE FOR CASH 6,020,306 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC.

EX-99.(a)(1)(E) EX-99.(a)(1)(E) OFFER TO PURCHASE FOR CASH 6,020,306 Shares of Common Stock of DYNACQ HEALTHCARE, INC. at $0.03 PER SHARE by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, ON MARCH 24, 2014, UNLESS EXTENDED. To Our Clients: Enclosed for your consideration are the Offer to Purchase dated February 19, 2014 and the related Letter of Tr

LETTER OF TRANSMITTAL To Tender shares of Common Stock Dynacq Healthcare, Inc. Pursuant to the Offer to Purchase dated February 19, 2014 Furlong Fund, LLC.

EX-99.(a)(1)(B) EX-99.(a)(1)(B) LETTER OF TRANSMITTAL To Tender shares of Common Stock of Dynacq Healthcare, Inc. Pursuant to the Offer to Purchase dated February 19, 2014 by Furlong Fund, LLC. THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT 12:00 MIDNIGHT, EASTERN TIME, ON MARCH 24, 2014, UNLESS THE OFFER IS EXTENDED. The Depositary for the Offer is: Transfer Online, Inc. Transfer Online, Inc. 512 SE S

- SCHEDULE TO-T

SC TO-T 1 scto-t.htm SCHEDULE TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYNACQ HEALTHCARE, INC. (Name of Subject Company (Issuer)) Furlong Fund, LLC; Furlong Financial, LLC (Bidders) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 2

Dynacq Healthcare FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2013 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number : 000-21574 DYNACQ H

Completion of Acquisition or Disposition of Assets - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 12, 2013 DYNACQ HEALTHCARE, INC.

DYII / Dynacq Healthcare, Inc. / Chan Ella Y. T. C. - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Ella Y. T. C. Chan 323 Wood Loop St. Houston, Texas 77015 (713) 582-0403 (Name, Address and Telephone Number of Pers

JOINT FILING AGREEMENT

EX-99.A Exhibit A JOINT FILING AGREEMENT The undersigned to this Joint Filing Agreement (“Agreement”) agree to the joint filing on behalf of each of them of the Statement (“Statement”) on Schedule 13D (Amendment No. 2) filed on or about the date hereof and any further amendments thereto with respect to beneficial ownership by the undersigned of the shares of common stock, par value $0.001 per shar

DYII / Dynacq Healthcare, Inc. / Chan Eric K. - SCHEDULE 13D/A NO.2 Activist Investment

SCHEDULE 13D/A NO.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Bert Chan 3836 Oberlin St. Houston, Texas 77005 (713) 875-3795 (Name, Address and Telephone Numb

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 8, 2013 DYNACQ HEALTHCARE, INC.

KWCO, PC Certified Public Accountants 1931 E. 37th Street, Suite 7 2626 Royal Circle Odessa, Texas 79762 Kingwood, Texas 77339 (432) 363-0067 (281) 359-7224 Fax (432) 363-0376 Fax (281) 359-7112

EX-16.1 Exhibit 16.1 KWCO, PC Certified Public Accountants 1931 E. 37th Street, Suite 7 2626 Royal Circle Odessa, Texas 79762 Kingwood, Texas 77339 (432) 363-0067 (281) 359-7224 Fax (432) 363-0376 Fax (281) 359-7112 April 15, 2013 Securities and Exchange Commission Washington, DC 20549 Dear Sirs: I have read the information, included in Form 8-K dated April 15, 2013, Items 4.01 (a), i, ii, iii, iv

NORTH TEXAS COMMERCIAL ASSOCIATION OF REALTORS® COMMERCIAL CONTRACT OF SALE (Check all boxes applicable to this Contract -Boxes not checked do not apply to this Contract)

EX-10.1 Exhibit 10.1 NORTH TEXAS COMMERCIAL ASSOCIATION OF REALTORS® COMMERCIAL CONTRACT OF SALE (Check all boxes applicable to this Contract -Boxes not checked do not apply to this Contract) In consideration of the agreements contained in this Commercial Contract of Sale (the “Contract”), Seller shall sell and convey to Purchaser, and Purchaser shall buy and pay for, the Property (defined below)

Financial Statements and Exhibits - FORM 8-K/A

Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A Amendment No.

Entry into a Material Definitive Agreement - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 7, 2013 DYNACQ HEALTHCARE, INC.

Other Events

8-K 1 d460003d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction

- FORM NT 10-K

Form NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-21574 (Check One) x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Repo

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation or organizat

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation) (Co

JAMES G. GERACE, P.C. CERTIFIED PUBLIC ACCOUNTANT P.O. Box 481 ¿ Baytown, Texas 77522-0481 E-mail: [email protected] MEMBER: AMERICAN INSTITUTE OF CERTIFIED PUBLIC ACCOUNTANTS TEXAS SOCIETY OF CERTIFIED PUBLIC ACCOUNTANTS OFFICE: 281.422.8183 FAX:

Resignation Letter of James G. Gerace Sent October 24, 2012 Exhibit 17.1 JAMES G. GERACE, P.C. CERTIFIED PUBLIC ACCOUNTANT P.O. Box 481 ¿ Baytown, Texas 77522-0481 E-mail: [email protected] MEMBER: AMERICAN INSTITUTE OF CERTIFIED PUBLIC ACCOUNTANTS TEXAS SOCIETY OF CERTIFIED PUBLIC ACCOUNTANTS OFFICE: 281.422.8183 FAX: 281.422.6575 October 19, 2012 VIA EMAIL Mr. Eric K. Chan Chief Executive Off

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation or o

- DEFINITIVE INFORMATION STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) þ Definitive Information Statement Dynacq Healthcare, Inc. (Name of Reg

-

Correspondence Letter DYNACQ HEALTHCARE, INC. 4301 VISTA ROAD, PASADENA, TEXAS 77504 October 4, 2012 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-4628 Attn: Jeffrey Riedler, Assistant Director Re: Dynacq Healthcare, Inc. Amendment No. 1 to Information Statement on Schedule 14C Filed October 3, 2012 File No. 000-21574 Ladies a

- REVISED PRELIMINARY INFORMATION STATEMENT

Revised Preliminary Information Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

-

Correspondence Letter DYNACQ HEALTHCARE, INC. 4301 VISTA ROAD, PASADENA, TEXAS 77504 October 2, 2012 BY EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-4628 Attn: Jeffrey Riedler, Assistant Director Re: Dynacq Healthcare, Inc. Information Statement on Schedule 14C Filed September 24, 2012 File No. 000-21574 Ladies and Gentlemen: On

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation or

DYII / Dynacq Healthcare, Inc. / Chan Bert - SCHEDULE 13D AMENDMENT NO. 1 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Bert Chan 3836 Oberlin St. Houston, Texas 77005 (713) 875-3795 (Name, Address and Telephone Number of Person Authori

DYII / Dynacq Healthcare, Inc. / Chan Ella Y. T. C. - SCHEDULE 13D AMENDMENT NO.1 Activist Investment

Schedule 13D Amendment No.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Ella Y. T. C. Chan 323 Wood Loop St. Houston, Texas 77015 (713) 582-0403 (Name, Address

- PRELIMINARY INFORMATION STATEMENT

Preliminary Information Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

COUNTY CLERK, HARRIS COUNTY, TEXAS PROBATE COURTS DEPARTMENT

EX-99.B EXHIBIT B STAN STANART COUNTY CLERK, HARRIS COUNTY, TEXAS PROBATE COURTS DEPARTMENT IN MATTERS OF PROBATE { { DOCKET NO. 413798 PROBATE COURT NO. Three (3) { { ESTATE OF: CHIU M. CHAN, DECEASED HARRIS COUNTY, TEXAS { LETTERS TESTAMENTARY Know all men by these presents that it is hereby certified: 1. On JULY 5, 2012, ELLA Y.T.C. CHAN was duly appointed by order of said court as INDEPENDENT

JOINT FILING AGREEMENT

EX-99.A EXHIBIT A JOINT FILING AGREEMENT The undersigned to this Joint Filing Agreement (“Agreement”) agree to the joint filing on behalf of each of them of the Statement (“Statement”) on Schedule 13D filed on or about the date hereof and any further amendments thereto with respect to beneficial ownership by the undersigned of the shares of common stock, par value $0.001 per share, of Dynacq Healt

DYII / Dynacq Healthcare, Inc. / Chan Ella Y. T. C. - SCHEDULE 13D Activist Investment

Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Ella Y. T. C. Chan 323 Wood Loop St. Houston, Texas 77015 (713) 582-0403 (Name, Address and Telephone Nu

DYII / Dynacq Healthcare, Inc. / Chan Bert - SCHEDULE 13D Activist Investment

SC 13D 1 d411381dsc13d.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Dynacq Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 26779V105 (CUSIP Number) Bert Chan 3836 Oberlin St. Houston, Texas 77005 (713) 875-3795 (Name, Address

JOINT FILING AGREEMENT

EX-99.A 2 d411381dex99a.htm EX-99.A EXHIBIT A JOINT FILING AGREEMENT The undersigned to this Joint Filing Agreement (“Agreement”) agree to the joint filing on behalf of each of them of the Statement (“Statement”) on Schedule 13D filed on or about the date hereof and any further amendments thereto with respect to beneficial ownership by the undersigned of the shares of common stock, par value $0.00

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation or or

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2012 Dynacq Healthcare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-21574 76-0375477 (State or other jurisdiction of incorporation or org

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2012 DYNACQ HEALTHCARE, INC.

Dynacq Healthcare Announces the Death of Chiu M. Chan, Founder and Chairman of the Board

Press Release Exhibit 99.1 Dynacq Healthcare Announces the Death of Chiu M. Chan, Founder and Chairman of the Board HOUSTON—(BUSINESS WIRE)—May 18, 2012—We are deeply saddened to announce that Chiu M. Chan, the Chairman and founder of Dynacq Healthcare, Inc. (NASDAQ:DYII), passed away yesterday morning. He had been incapacitated by an unexpected illness since January of this year. He was 59. Our h

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 12, 2012 DYNACQ HEALTHCARE, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2012 DYNACQ HEALTHCARE, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2012 DYNACQ HEALTHCARE, INC.